Morning Market Losers

shares dipped 49.82% to $2.78 following news that top-line results from Phase II/III trial for CF101 did not hit primary efficacy endpoint.

fell 27.37% to $3.91 after the company reported that it has received a Complete Response Letter from the FDA for Epinephrine Pre-Filled Syringe NDA.

shares slipped 24.47% to $10.49. BioDelivery Sciences reported that the primary endpoint in Phase 3 study of Clonidine Topical Gel for painful diabetic neuropathy did not met statistical significance.

tumbled 9.21% to $7.00 after the company reported Q4 earnings of $0.56 per share on revenue of $17.9 million.

shares dropped 5.34% to $58.34 after the company announced the commencement of a 35 million share secondary offering of portion of Abbott's ordinary shares.

shares declined 3.20% to $2.42 after the company reported Q4 earnings of $0.01 per share on sales of $3.99 million.

shares dipped 2.8% to $5.73. EIG Global Energy Partners announced its plans to invest $1 billion in Breitburn Energy Partners. Wunderlich downgraded BreitBurn Energy Partners from Hold to Sell and lowered the price target from $9.00 to $4.00.

shares declined 2.41% to $8.91. Silver futures fell 1.66% to trade at $16.79 an ounce.

dropped 1.31% to $31.58. According to a report from the Wall Street Journal, Altera Corp

is in talks to be acquired by Intel.